Your browser doesn't support javascript.
loading
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.
Manier, S; Park, J; Capelletti, M; Bustoros, M; Freeman, S S; Ha, G; Rhoades, J; Liu, C J; Huynh, D; Reed, S C; Gydush, G; Salem, K Z; Rotem, D; Freymond, C; Yosef, A; Perilla-Glen, A; Garderet, L; Van Allen, E M; Kumar, S; Love, J C; Getz, G; Adalsteinsson, V A; Ghobrial, I M.
Afiliação
  • Manier S; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Park J; Hematology Department, CHU, Univ. Lille, 59000, Lille, France.
  • Capelletti M; INSERM UMR-S1172, 59000, Lille, France.
  • Bustoros M; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Freeman SS; Brigham and Women's Hospital, Boston, MA, 02115, USA.
  • Ha G; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Rhoades J; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Liu CJ; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
  • Huynh D; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
  • Reed SC; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
  • Gydush G; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Salem KZ; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Rotem D; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
  • Freymond C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
  • Yosef A; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Perilla-Glen A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
  • Garderet L; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Van Allen EM; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Kumar S; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Love JC; Department of Hematology, St-Antoine University Hospital, Paris, 75000, France.
  • Getz G; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Adalsteinsson VA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
  • Ghobrial IM; Department of Hematology, Mayo Clinic, Rochester, MN, 55902, USA.
Nat Commun ; 9(1): 1691, 2018 04 27.
Article em En | MEDLINE | ID: mdl-29703982
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / DNA Tumoral Circulante / Sequenciamento do Exoma / Mieloma Múltiplo / Células Neoplásicas Circulantes Tipo de estudo: Evaluation_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / DNA Tumoral Circulante / Sequenciamento do Exoma / Mieloma Múltiplo / Células Neoplásicas Circulantes Tipo de estudo: Evaluation_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article